Sign In
Upcoming Event
Free Newsletter
B. Braun’s $20M Lehigh Valley expansion, creating 200 jobs, was highlighted by Site Selection magazine as Pennsylvania ranks top in Northeast business climate. PHOTO/FILE
B. Braun launches largest U.S. premixed heparin line
Stacy Wescoe//July 21, 2025//
Listen to this articleBethlehem’s B. Braun Medical Inc. has announced the launch of its new Heparin Sodium Injections into the U.S. market.
The products are used as anticoagulants for use with catheters.
The company said these launches expand its portfolio to include 25,000 Units Heparin in 0.45% Sodium Chloride Injection and 25,000 Units Heparin in 0.45% Sodium Chloride Injection. B. Braun added this is the largest offering of Heparin Premixed bags in the U.S. market.
The 250 mL and 500 mL bags will feature a 2D enhanced barcode. The 2D enhanced barcode design includes the National Drug Code (NDC) number, lot number and expiration date, along with increased spacing between the two 1D barcodes. These enhancements are designed to help improve the accuracy and efficiency of barcode scanning.
The B. Braun Heparin portfolio is manufactured using EXCEL IV Containers, which are not made with DEHP, PVC or natural rubber latex, prioritizing patient and environmental safety.
“Expanding our Heparin Sodium Injection portfolio underscores our commitment to healthcare providers and their patients. By offering the largest selection of premixed Heparin products in the market, we are helping to provide healthcare workers with the tools they need to deliver precise and effective care,” said Shawn Brinson, Director of Marketing, Injectable Drugs, B. Braun Medical Inc.
